Adrenal masses in the cancer patient: Surveillance or excision

Oncologist

Volumn 12, Issue 2, 2007, Pages 168-174

  Mitchell, Ian C ^a   Nwariaku, Fiemu E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adrenal gland neoplasms secondary; Adrenal gland neoplasms surgery; Adrenalectomy; Positron emission tomography; X ray spiral computed tomography

Indexed keywords

ADRENAL BIOPSY; ADRENAL CANCER; ADRENAL CORTEX HYPERFUNCTION; ADRENAL DISEASE; ADRENAL MEDULLA DISEASE; ADRENAL METASTASIS; ADRENALECTOMY; BIOCHEMISTRY; CANCER PATIENT; CANCER SURGERY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; EVALUATION; EVIDENCE BASED MEDICINE; HEALTH SURVEY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PERCUTANEOUS BIOPSY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; TUMOR BIOPSY; TUMOR VOLUME;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ANTINEOPLASTIC AGENTS; BIOPSY, NEEDLE; DIAGNOSTIC IMAGING; HUMANS; NEOPLASMS;

EID: 33847014169     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.12-2-168     Document Type: Review

References (48)

1. Abecassis M, McLoughlin MJ, Langer B et al. Serendipitous adrenal masses: Prevalence, significance, and management. Am J Surg 1985;149:783-788.
2. Kloos RT, Gross MD, Francis IR et al. Incidentally discovered adrenal masses. Endocr Rev 1995;16:460-484.
3. Hedeland H, Ostberg G, Hokfelt B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 1968;184:211-214.
4. Lenert JT, Barnett CC Jr, Kudelka AP et al. Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery 2001;130:1060-1067.
5. Sagalowsky AI, Molberg K. Solitary metastasis of renal cell carcinoma to the contralateral adrenal gland 22 years after nephrectomy. Urology 1999;54:162.
6. Crapo L. Cushing's syndrome: A review of diagnostic tests. Metabolism 1979;28:955-977.
7. Arnaldi G, Angeli A, Atkinson AB et al. Diagnosis and complications of Cushing's syndrome: A consensus statement. J Clin Endocrinol Metab 2003;88:5593-5602.
8. Wood PJ, Barth JH, Freedman DB et al. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome - recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997;34(Pt 3):222-229.
9. Young WF Jr. Pheochromocytoma and primary aldosteronism: Diagnostic approaches. Endocrinol Metab Clin North Am 1997;26:801-827.
10. Weinberger MH, Fineberg NS. The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med 1993;153:2125-2129.
11. Lenders JW, Pacak K, Walther MM et al. Biochemical diagnosis of pheochromocytoma: Which test is best? JAMA 2002;287:1427-1434.
12. Eisenhofer G, Lenders JW, Linehan WM et al. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 1999;340:1872-1879.
13. Eisenhofer G, Lenders JW, Pacak K. Choice of biochemical test for diagnosis of pheochromocytoma: Validation of plasma metanephrines. Curr Hypertens Rep 2002;4:250-255.
14. Unger N, Pitt C, Schmidt IL et al. Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol 2006;154:409-417.
15. Korobkin M, Francis IR. Imaging of adrenal masses. Urol Clin North Am 1997;24:603-622.
16. Boland GW, Lee MJ, Gazelle GS et al. Characterization of adrenal masses using unenhanced CT: An analysis of the CT literature. AJR Am J Roentgenol 1998;171:201-204.
17. Korobkin M, Brodeur FJ, Francis IR et al. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 1998;170:747-752.
18. Szolar DH, Kammerhuber FH. Adrenal adenomas and nonadenomas: Assessment of washout at delayed contrast-enhanced CT. Radiology 1998;207:369-375.
19. Szolar DH, Korobkin M, Reittner P et al. Adrenocortical carcinomas and adrenal pheochromocytomas: Mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 2005;234:479-485.
20. Blake MA, Kalra MK, Sweeney AT et al. Distinguishing benign from malignant adrenal masses: Multi-detector row CT protocol with 10-minute delay. Radiology 2006;238:578-585.
21. Mitchell DG, Crovello M, Matteucci T et al. Benign adrenocortical masses: Diagnosis with chemical shift MR imaging. Radiology 1992;185:345-351.
22. Honigschnabl S, Gallo S, Niederle B et al. How accurate is MR imaging in characterisation of adrenal masses: Update of a long-term study. Eur J Radiol 2002;41:113-122.
23. Outwater EK, Mitchell DG. Differentiation of adrenal masses with chemical shift MR imaging. Radiology 1994;193:877-878.
24. Outwater EK, Siegelman ES, Radecki PD et al. Distinction between benign and malignant adrenal masses: Value of T1-weighted chemical-shift MR imaging. AJR Am J Roentgenol 1995;165:579-583.
25. Schwartz LH, Panicek DM, Koutcher JA et al. Echoplanar MR imaging for characterization of adrenal masses in patients with malignant neoplasms: Preliminary evaluation of calculated T2 relaxation values. AJR Am J Roentgenol 1995;164:911-915.
26. Reinig JW, Doppman JL, Dwyer AJ et al. MRI of indeterminate adrenal masses. AJR Am J Roentgenol 1986;147:493- 496.
27. Lumachi F, Tregnaghi A, Zucchetta P et al. Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: A prospective study. Nucl Med Commun 2006;27:583-587.
28. Boland GW, Goldberg MA, Lee MJ et al. Indeterminate adrenal mass in patients with cancer: Evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995;194:131-134.
29. Erasmus JJ, Patz EF Jr, McAdams HP et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 1997;168:1357-1360.
30. Gupta NC, Graeber GM, Tamim WJ et al. Clinical utility of PET-FDG imaging in differentiation of benign from malignant adrenal masses in lung cancer. Clin Lung Cancer 2001;3:59-64.
31. Yun M, Kim W, Alnafisi N et al. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 2001;42:1795-1799.
32. Kumar R, Xiu Y, Yu JQ et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004;45:2058-2062.
33. Metser U, Miller E, Lerman H et al. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 2006;47:32-37.
34. Blake MA, Slattery JM, Kalra MK et al. Adrenal lesions: Characterization with fused PET/CT image in patients with proved or suspected malignancy - initial experience. Radiology 2006;238:970-977.
35. Grumbach MM, Biller BM, Braunstein GD et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 2003;138:424-429.
36. Hussain S. Gantry angulation in CT-guided percutaneous adrenal biopsy. AJR Am J Roentgenol 1996;166:537-539.
37. Welch TJ, Sheedy PF 2nd, StephensDHet al. Percutaneous adrenal biopsy: review of a 10-year experience. Radiology 1994;193:341-344.
38. Beitler AL, Urschel JD, Velagapudi SR et al. Surgical management of adrenal metastases from lung cancer. J Surg Oncol 1998;69:54-57.
39. Sarela AI, Murphy I, Coit DG et al. Metastasis to the adrenal gland: The emerging role of laparoscopic surgery. Ann Surg Oncol 2003;10:1191-1196.
40. Kim SH, Brennan MF, Russo P et al. The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 1998;82:389-394.
41. Lo CY, van Heerden JA, Soreide JA et al. Adrenalectomy for metastatic disease to the adrenal glands. Br J Surg 1996;83:528-531.
42. Heniford BT, Arca MJ, Walsh RM et al. Laparoscopic adrenalectomy for cancer. Semin Surg Oncol 1999;16:293-306.
43. Kebebew E, Siperstein AE, Clark OH et al. Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. Arch Surg 2002;137:948-951; discussion 952-953.
44. Barzon L, Scaroni C, Sonino N et al. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1999;84:520-526.
45. Barry MK, van Heerden JA, FarleyDRet al. Can adrenal incidentalomas be safely observed? World J Surg 1998;22:599-603; discussion 603-604.
46. Bernini GP, Moretti A, Oriandini C et al. Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas. Br J Cancer 2005;92:1104-1109.
47. Momoi H, Shimahara Y, Terajima H et al. Management of adrenal metastasis from hepatocellular carcinoma. Surg Today 2002;32:1035-1041.
48. Mayo-Smith WW, Dupuy DE. Adrenal neoplasms: CT-guided radiofrequency ablation - preliminary results. Radiology 2004;231:225-230.